Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing ribozymes for somatic cell gene therapy

A D Branch1, P E Klotman

  • 1Division of Liver Diseases (Department of Medicine), Mount Sinai Medical Center, New York, N.Y. 10029, USA. ab8@doc.mssm.edu

Experimental Nephrology
|April 2, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High baseline bilirubin and low albumin predict liver decompensation and serious adverse events in HCV-infected patients treated with sofosbuvir-containing regimens.

Journal of viral hepatitis·2016
Same author

Clinical characteristics of human immunodeficiency virus patients being referred for liver transplant evaluation: a descriptive cohort study.

Transplant infectious disease : an official journal of the Transplantation Society·2015
Same author

Commentary: real-world triple therapy experience treating hepatitis C virus - authors' reply.

Alimentary pharmacology & therapeutics·2014
Same author

Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir.

Alimentary pharmacology & therapeutics·2013
Same author

Detection and localization of HIV-1 DNA in renal tissues by in situ polymerase chain reaction.

Histology and histopathology·2006
Same author

The coming impact of gene expression profiling on the diagnosis and treatment of HCV-associated liver disease.

Antiviral research·2001
Same journal

Mixed bone marrow or mixed stem cell transplantation for prevention or treatment of lupus-like diseases in mice.

Experimental nephrology·2002
Same journal

Segregation of experimental autoimmune glomerulonephritis as a complex genetic trait and exclusion of Col4a3 as a candidate gene.

Experimental nephrology·2002
Same journal

Activation of peroxisome proliferator-activated receptor-gamma inhibits apoptosis induced by serum deprivation in LLC-PK1 cells.

Experimental nephrology·2002
Same journal

Characterization of adenosine receptors in human kidney proximal tubule (HK-2) cells.

Experimental nephrology·2002
Same journal

Altered renin synthesis and secretion in the kidneys of heterozygous mice with a null mutation in the TGF-beta(2) gene.

Experimental nephrology·2002
Same journal

Induction of alpha-catenin, integrin alpha3, integrin beta6, and PDGF-B by 2,8-dihydroxyadenine crystals in cultured kidney epithelial cells.

Experimental nephrology·2002
See all related articles

Designing therapeutic ribozymes for gene therapy is complex. This study outlines methods and control molecules needed to rigorously test hammerhead and hairpin ribozymes for gene ablation, specificity, and selectivity.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Biochemistry

Background:

  • Therapeutic ribozyme development is an empirical process with limited design rules.
  • Hammerhead and hairpin ribozymes are key candidates for gene therapy applications.
  • The gene ablation, specificity, and selectivity of these ribozymes require further investigation.

Purpose of the Study:

  • To present methods for ribozyme development, from target gene selection to RNA quantitation.
  • To outline the characteristics of essential control molecules for experimental validation.
  • To address the need for rigorous experimentation to explore ribozyme capabilities.

Main Methods:

  • Detailed description of the ribozyme development process.
  • Specification of control molecules for experimental design.

Related Experiment Videos

  • Methodologies for target gene selection and RNA level quantitation.

    • Main Results:

    • Guidelines for ribozyme design are emerging.
    • The study provides a framework for experimental validation of ribozyme function.
    • Essential control molecules are characterized for future studies.

    Conclusions:

    • Rigorous experimentation is necessary to determine the gene ablation, specificity, and selectivity of hammerhead and hairpin ribozymes.
    • The presented methods and control molecules will facilitate future research in therapeutic ribozyme development.
    • Further studies are required to establish the full potential of ribozymes in gene therapy.